First human tests begin for new nerve pain drug
Knowledge-focused
Not yet recruiting
This is the first study in people to test the safety of a potential new drug called ASCT-83, which is being developed for neuropathic pain. It will involve 72 healthy adults to check for side effects and see how the drug moves through the body. The goal is to find safe dose level…
Phase: PHASE1 • Sponsor: Alcamena Stem Cell Therapeutics • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:27 UTC